intubation. Failed or difficult intubation
Conditions
Interventions
Treatment - Drugs
Intervention 1: Intervention: Diazepam (each ampoule contains10mg/2ml , made by Kimidaroo/Iran) injecting IV with dosage of 0.4mg/kg before induction of anesthesia. Intervention 2: Control group: Etom
Intervention: Diazepam (each ampoule contains10mg/2ml , made by Kimidaroo/Iran) injecting IV with dosage of 0.4mg/kg before induction of anesthesia
Control group: Etomidate (each ampoule contains20mg/10ml , made by Janssen-Cling/Australia) injecting IV and stat with dosage of 0.3mg/kg before induction of anesthesia
Sponsors
Deputy of Research Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
25 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria are: American Association of Anesthesiologists’ (ASA) classification of I or II; age 25 -65 years. Exclusion criteria are: ASA classification of 3-6 (severe systemic disorders such as CRF and CHF); patients with fever, anemia, seasonal or food allergy or known medicine hypersensitivity; hypertension;, hypo tension; consumption of beta blockers; kidney and liver disorders; drug abuse; dehydration and anxious patients with heart rate of100 b/m or more.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: after lying on surgical bed, immediately after intubation, 5 and 10 minutes later. Method of measurement: digital monitoring device.;Heart rate. Timepoint: after lying on surgical bed, immediately after intubation, 5 and 10 minutes later. Method of measurement: digital monitoring device. | — |
Secondary
| Measure | Time frame |
|---|---|
| Awareness. Timepoint: at the end of anesthesia. Method of measurement: asking the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahdi Khodadadzadeh
Kerman University of Medical Sciences
Outcome results
None listed